These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 29964132

  • 41. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
    Han YH, Busler D, Hong Y, Tian Y, Chen C, Rodrigues AD.
    Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
    [Abstract] [Full Text] [Related]

  • 42. Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.
    Wood CE, Cousins R, Zhang D, Keller-Wood M.
    Exp Biol Med (Maywood); 2005 Oct; 230(9):668-73. PubMed ID: 16179735
    [Abstract] [Full Text] [Related]

  • 43. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
    Caetano-Pinto P, Jamalpoor A, Ham J, Goumenou A, Mommersteeg M, Pijnenburg D, Ruijtenbeek R, Sanchez-Romero N, van Zelst B, Heil SG, Jansen J, Wilmer MJ, van Herpen CML, Masereeuw R.
    Mol Pharm; 2017 Jun 05; 14(6):2147-2157. PubMed ID: 28493713
    [Abstract] [Full Text] [Related]

  • 44. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
    Nigam AK, Li JG, Lall K, Shi D, Bush KT, Bhatnagar V, Abagyan R, Nigam SK.
    J Biol Chem; 2020 Feb 14; 295(7):1829-1842. PubMed ID: 31896576
    [Abstract] [Full Text] [Related]

  • 45. Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction.
    Villar SR, Brandoni A, Anzai N, Endou H, Torres AM.
    Kidney Int; 2005 Dec 14; 68(6):2704-13. PubMed ID: 16316345
    [Abstract] [Full Text] [Related]

  • 46. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z, Tachikawa M, Uchida Y, Terasaki T.
    Mol Pharm; 2018 Mar 05; 15(3):911-922. PubMed ID: 29436232
    [Abstract] [Full Text] [Related]

  • 47. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
    Nishizawa K, Yoda N, Morokado F, Komori H, Nakanishi T, Tamai I.
    PLoS One; 2019 Mar 05; 14(4):e0214862. PubMed ID: 30951542
    [Abstract] [Full Text] [Related]

  • 48. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU, Kwon M, Lee Y, Yoo JS, Shin DH, Song IS, Lee HS.
    Drug Des Devel Ther; 2015 Mar 05; 9():643-53. PubMed ID: 25653502
    [Abstract] [Full Text] [Related]

  • 49. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
    Shen H, Yao M, Sinz M, Marathe P, Rodrigues AD, Zhu M.
    Mol Pharm; 2019 Sep 03; 16(9):4065-4076. PubMed ID: 31335150
    [Abstract] [Full Text] [Related]

  • 50. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
    Ulu R, Dogukan A, Tuzcu M, Gencoglu H, Ulas M, Ilhan N, Muqbil I, Mohammad RM, Kucuk O, Sahin K.
    Food Chem Toxicol; 2012 May 03; 50(5):1675-9. PubMed ID: 22414646
    [Abstract] [Full Text] [Related]

  • 51. Glucocorticoid mediates the transcription of OAT-PG, a kidney-specific prostaglandin transporter.
    Hatano R, Mukouchi H, Matsumoto Y, Kawaguchi K, Kazama I, Endo Y, Toyama H, Ejima Y, Kurosawa S, Kanai Y, Matsubara M, Asano S.
    Pflugers Arch; 2014 May 03; 466(5):925-35. PubMed ID: 24057348
    [Abstract] [Full Text] [Related]

  • 52. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
    Yaro P, Nie J, Xu M, Zeng K, He H, Yao J, Wang R, Zeng S.
    J Ethnopharmacol; 2019 Oct 28; 243():112098. PubMed ID: 31325605
    [Abstract] [Full Text] [Related]

  • 53. Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro.
    Zhang Y, Han YH, Putluru SP, Matta MK, Kole P, Mandlekar S, Furlong MT, Liu T, Iyer RA, Marathe P, Yang Z, Lai Y, Rodrigues AD.
    Drug Metab Dispos; 2016 Mar 28; 44(3):320-8. PubMed ID: 26714763
    [Abstract] [Full Text] [Related]

  • 54. Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney.
    Ogasawara K, Terada T, Motohashi H, Asaka JI, Aoki M, Katsura T, Kamba T, Ogawa O, Inui KI.
    J Hum Genet; 2008 Mar 28; 53(7):607-614. PubMed ID: 18414781
    [Abstract] [Full Text] [Related]

  • 55. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G, Bhatnagar V, Wen G, Hamilton BA, Eraly SA, Nigam SK.
    Kidney Int; 2005 Oct 28; 68(4):1491-9. PubMed ID: 16164626
    [Abstract] [Full Text] [Related]

  • 56. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R, Lao Y, Bow DA, Chiou WJ, Andracki ME, Carr RA, Voorman RL, De Morais SM.
    J Pharm Sci; 2013 Dec 28; 102(12):4426-32. PubMed ID: 24122511
    [Abstract] [Full Text] [Related]

  • 57. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S, Le Vee M, Jouan E, Fardel O.
    J Biochem Mol Toxicol; 2014 Mar 28; 28(3):119-28. PubMed ID: 24464585
    [Abstract] [Full Text] [Related]

  • 58. Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2.
    Habu Y, Yano I, Takeuchi A, Saito H, Okuda M, Fukatsu A, Inui K.
    Biochem Pharmacol; 2003 Sep 15; 66(6):1107-14. PubMed ID: 12963498
    [Abstract] [Full Text] [Related]

  • 59. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.
    Liu HC, Goldenberg A, Chen Y, Lun C, Wu W, Bush KT, Balac N, Rodriguez P, Abagyan R, Nigam SK.
    J Pharmacol Exp Ther; 2016 Oct 15; 359(1):215-29. PubMed ID: 27488918
    [Abstract] [Full Text] [Related]

  • 60. Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats.
    Guo X, Meng Q, Liu Q, Wang C, Mao Q, Sun H, Peng J, Kaku T, Liu K.
    Drug Metab Pharmacokinet; 2012 Oct 15; 27(2):232-41. PubMed ID: 22123131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.